Results 51 to 60 of about 130,554 (162)
, 2009 The aim of the present study is to clarify the low density lipoprotein apheresis procedure for pediatric patients with homozygous familial hypercholesterolemia (FH) in terms of efficacy, adverse effects and difficulties.
Darcan, Sukran +5 more
core +1 more source
Apheresis In Developing Countries Around The World
, 2016 At the combined American Society for Apheresis (ASFA) Annual Meeting/World Apheresis Association (WAA) Congress in San Francisco, California, in April of 2014, the opening session highlighted the status of apheresis outside of the United States.
Jr.; Comenalli Marques +9 more
core +2 more sources
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016 BackgroundApheresis is an important treatment for reducing low‐density lipoprotein cholesterol (LDL‐C) in patients with familial hypercholesterolemia (FH). We systematically reviewed the current literature surrounding LDL‐C apheresis for FH.
Anthony Wang +7 more
doaj +1 more source
, 2016 Continuing education and standardization are of utmost importance in apheresis science as every field in medicine. Especially, the last 5 years witnessed remarkable progress in apheresis science in Turkey, both in terms of increased numbers of ...
Sencan, Irfan +11 more
core +1 more source
American Journal of Preventive Cardiology, 2023 Therapeutic Area: ASCVD /CVD Risk Reduction Background: Homozygous familial hypercholesterolemia (HoFH) is a rare genetic disorder characterized by severely elevated low-density lipoprotein cholesterol (LDL-C) levels.
Albert Wiegman +15 more
doaj +1 more source
Clinical outcomes, perfusion and vascular function in patients with refractory angina and raised lipoprotein (a), treated with lipoprotein apheresis [PDF]
, 2017 Background: Angina which is refractory to conventional medical therapy and revascularisation is challenging to manage and novel therapeutic options are needed.
Khan, Tina
core +1 more source
Journal of Lipid Research, 2000 Epidemiologic studies and in vitro experiments indicate that low density lipoprotein (LDL) subtypes differ concerning their atherogenic potential. Small, dense LDL are more atherogenic than large, buoyant LDL.
B.M. Schamberger +4 more
doaj +1 more source
Pollens derived magnetic porous particles for adsorption of low-density lipoprotein from plasma
Bioactive Materials, 2021 Adsorption of low-density lipoprotein from plasma is vital for the treatment of dyslipidemia. Appropriate adsorbent material for efficient and selective adsorption of low-density lipoprotein is highly desired.
Yuetong Wang +6 more
doaj +1 more source
Low density lipoprotein apheresis [PDF]
, 2003 Increased blood cholesterol concentration is one of the main factors in ischemic heart disease, development of which is determined by atherosclerotic changes in coronary vessels.
Vaitkus, Eduardas +4 more
core
Muscle &Nerve, Volume 73, Issue 6, Page 942-951, June 2026.ABSTRACT This review examines the emerging application of chimeric antigen receptor (CAR) T‐cell therapy in myasthenia gravis (MG), with emphasis on safety, efficacy signals, and future therapeutic potential in treatment‐refractory disease. A comprehensive literature search was conducted across PubMed, medRxiv, bioRxiv, and Google Scholar for studies ...
Tobias Hegelmaier +7 more
wiley +1 more source